-----

Welcome to the April 2012 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, analysis of Merck & Co.’s and MedImmune’s biologics manufacturing capacity-sharing arrangement. Also, analysis of the recent ruling supporting compulsory licensing for a pharmaceutical in India. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Biologics
Manufacturing Capacity-Sharing Model: Merck & Co. and MedImmune
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Merck & Co. and MedImmune's manufacturing capacity-sharing model for biologics ushers in a new paradigm of "co-opetition." >> Read More

APIs
Pharmaceutical Industry Faces Compulsory Licensing in India
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
The decision by the Indian Patent Office to issue a compulsory license for a generic version of a Bayer anticancer drug engenders debate.
>> Read More

Outsourcing
CMOs Face a Kodak Moment
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
The evolving bio/pharmaceutical business model poses risk for CMOs.
>> Read More

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on a new UN Commission focused on health treatments for women and children and a roundup of CSR and sustainability news.

UN Launches Commission on Life-Saving Commodities for Women and Children
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
A new UN organization focuses on improving the delivery of essential health supplies, including strengthening local production capacities, promoting new technologies and products, strengthening regulatory frameworks, and enhancing innovative financing mechanisms. >> Read More

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

April
Apr. 12
Free Live Webcast from Pharmaceutical Technology: "Risk Management in Sterile Manufacturing"
2:00 PM - 3:00 PM EST; 11:00 AM - 12:00 PM PST
Register here

Apr. 16–18
PDA Annual Meeting
Phoenix, AZ

May
May 8–9
Chemspec USA
Philadelphia

May 22–23
ICSE USA
Philadelphia

June
June 18–21
2012 BIO International Convention
Boston

June 21–22
SustaiNEXT EU
Dublin, Ireland